— Know what they know.
Not Investment Advice
Also trades as: GLENMARK.BO (BSE) · $vol 1M

GLENMARK.NS NSE

Glenmark Pharmaceuticals Limited
1W: -4.1% 1M: -5.6% 3M: +5.4% YTD: +19.1% 1Y: +15.0% 3Y: +187.3% 5Y: +302.6%
₹2,331.00 ($24.21)
-3.70 (-0.16%)
 
NSE · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Sell · Power 40 · ₹657.8B mcap · 142M float · 0.422% daily turnover

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

D+
Oct 01, 2026
DCF
1
ROE
1
ROA
1
D/E
1
P/E
1
P/B
1
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. GLENMARK.NS receives an overall rating of D+. Areas of concern: DCF (1/5), ROE (1/5), ROA (1/5), D/E (1/5), P/E (1/5), P/B (1/5).
Rating Change History
DateFromTo
2026-08-03 B D+
2026-07-31 B- B
2026-06-01 D+ B-
2026-02-01 B- D+
2026-01-13 C- B-

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 72 Grade A+
Profitability
47
Balance Sheet
80
Earnings Quality
54
Growth
77
Value
37
Momentum
100
Safety
100
Cash Flow
68
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. GLENMARK.NS scores highest in Safety (100/100) and lowest in Value (37/100). An overall grade of A+ places GLENMARK.NS among the highest-quality companies in its peer group.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
6.05
Safe Zone
Piotroski F-Score
8/9
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✗ ✓
Beneish M-Score
-2.30
Unlikely Manipulator
Ohlson O-Score
-10.24
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA+
Score: 92.0/100
Trend: Improving
Earnings Quality
75/100
OCF/NI: 2.38x
Accruals: -10.5%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. GLENMARK.NS scores 6.05, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. GLENMARK.NS scores 8/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. GLENMARK.NS's score of -2.30 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. GLENMARK.NS's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. GLENMARK.NS receives an estimated rating of AA+ (score: 92.0/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). GLENMARK.NS's score of 75/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
36.59x
PEG
0.26x
P/S
3.71x
P/B
6.26x
P/FCF
29.61x
P/OCF
18.53x
EV/EBITDA
21.53x
EV/Revenue
3.51x
EV/EBIT
27.16x
EV/FCF
29.32x
Earnings Yield
2.26%
FCF Yield
3.38%
Shareholder Yield
0.12%
Graham Number
$635.93
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 36.6x earnings, GLENMARK.NS commands a growth premium. Graham's intrinsic value formula yields $635.93 per share, 267% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.686
NI / EBT
×
Interest Burden
0.905
EBT / EBIT
×
EBIT Margin
0.129
EBIT / Rev
×
Asset Turnover
0.945
Rev / Assets
×
Equity Multiplier
1.857
Assets / Equity
=
ROE
14.1%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. GLENMARK.NS's ROE of 14.1% is driven by Asset Turnover (0.945), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Two adjustments we make, and why. Growth is capped at 15%. Graham defined g as expected growth over the next seven to ten years, not last year's rate. Across US companies since 1994 the median realized 7-year EPS growth is 5–8% regardless of how fast a company grew beforehand, and of 4,457 company-quarters that grew faster than 200%, none sustained it. Uncapped, the formula assigned fair multiples in the hundreds to companies that had never held that rate — and scored worse than simply reading the P/E. Capped, it carries real information. The verdict has three states, not two. Tested over 377,249 stock-months, this ratio only separates outcomes at its extremes: below 0.25 beat the universe by 1.3 points a year, above 3.0 lagged by 2.7, and everything in between sat inside a one-point band. Rather than call two-thirds of the market "undervalued" on a threshold of 1.0, we say Neutral where the model cannot tell — which is most of the time.

Adj. Growth Rate
15.00%
Fair P/E
38.50x
Intrinsic Value
$1857.80
Price/Value
1.15x
Margin of Safety
-14.74%
Premium
14.74%
Assessment
Neutral
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with GLENMARK.NS's realized 15.0% 3-year EPS CAGR, capped at 15% — demonstrated performance rather than forecasts, held to a rate companies have historically sustained. GLENMARK.NS actually compounded EPS at 66.1% over three years; the model uses 15%, the highest rate it will extrapolate — of 4,457 company-quarters that grew faster than 200%, none sustained it over the following seven years. GLENMARK.NS trades at a 15% premium to its adjusted intrinsic value of $1857.80, suggesting the market is pricing in future growth beyond what historical earnings support. The adjusted fair P/E of 38.5x compares to the current market P/E of 36.6x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$2331.00
Median 1Y
$2662.21
5th Pctile
$1474.46
95th Pctile
$4797.46
Ann. Volatility
37.3%
25th–75th percentile 5th–95th percentile Median path Historical
All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
ROE 15.6% 13.8% 13.5% 11.7% 10.2% 9.1% 9.7% 3.2% 2.7% -0.9% -7.5% -17.3% -15.1% -9.8% -2.0% 12.5% 9.0% 11.2% 11.8% 14.1% 14.07%
ROA 6.8% 6.6% 6.4% 5.8% 5.1% 4.8% 5.1% 1.6% 1.4% -0.5% -3.7% -8.9% -7.8% -5.0% -1.0% 6.9% 5.0% 5.9% 6.2% 7.6% 7.57%
ROIC 20.3% 21.0% 22.4% 21.2% 18.7% 15.5% 15.2% 10.9% 11.0% 27.2% 22.2% -3.8% -2.2% -50.8% -5.9% 32.0% 23.9% 26.9% 20.0% 23.6% 23.58%
ROCE 15.9% 15.6% 17.0% 14.8% 13.0% 11.7% 10.8% 4.4% 5.8% 4.8% -1.0% 19.1% 19.0% 19.7% 29.2% 18.2% 15.1% 17.2% 17.8% 16.2% 16.21%
Gross Margin 62.3% 63.5% 66.4% 59.7% 63.6% 65.4% 66.3% 36.5% 63.9% 62.7% 58.8% 70.2% 65.8% 68.8% 68.3% 60.6% 41.5% 58.8% 41.3% 41.5% 41.45%
Operating Margin 42.6% 41.6% 48.0% -18.9% 40.6% 34.0% 44.5% 8.8% 42.5% 39.8% 28.8% 5.9% 43.9% 45.9% 45.2% -13.6% 13.8% 26.9% 18.3% 16.3% 16.30%
Net Margin 10.1% 8.2% 7.0% 5.3% 6.9% 7.7% 7.9% -14.3% 4.4% -2.6% -14.0% -31.3% 10.5% 10.3% 10.2% 0.1% 1.4% 10.1% 10.3% 8.0% 7.99%
EBITDA Margin 20.8% 18.3% 20.2% 10.0% 14.6% 18.3% 13.7% -14.8% 18.5% 14.8% -11.3% 32.9% 19.4% 17.5% 17.7% 13.8% 8.7% 19.4% 18.7% 15.3% 15.34%
FCF Margin 2.8% 2.6% 2.3% 2.2% 2.2% 4.0% 5.8% 5.7% 7.2% 7.1% 7.4% 4.6% -0.0% -4.4% -8.3% -9.5% -10.3% 7.9% 7.0% 12.0% 11.97%
OCF Margin 8.5% 7.8% 7.0% 7.0% 7.1% 7.1% 7.3% 7.3% 7.2% 7.1% 7.4% 6.3% 3.5% 0.7% -1.9% -3.1% -4.1% 14.8% 13.5% 19.1% 19.12%
ROE 3Y Avg snapshot only 1.88%
ROE 5Y Avg snapshot only 3.83%
ROA 3Y Avg snapshot only 0.97%
ROIC 3Y Avg snapshot only 7.27%
ROIC Economic snapshot only 21.73%
Cash ROA snapshot only 16.31%
Cash ROIC snapshot only 32.73%
CROIC snapshot only 20.48%
NOPAT Margin snapshot only 13.77%
Pretax Margin snapshot only 11.69%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 16.18%
SBC / Revenue snapshot only 0.03%
Valuation
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
P/E Ratio 17.71 13.60 14.45 13.09 13.02 13.13 13.51 43.86 74.53 -274.78 -33.77 -17.96 -26.40 -53.89 -257.92 42.72 65.62 54.52 53.95 44.18 36.588
P/S Ratio 1.57 1.21 1.21 1.00 0.89 0.89 0.95 1.03 1.43 1.84 1.98 2.07 2.69 3.61 3.24 3.37 3.71 3.46 3.50 3.54 3.709
P/B Ratio 2.56 1.64 1.70 1.36 1.19 1.14 1.24 1.38 2.00 2.58 2.58 3.44 4.41 5.58 5.37 5.05 5.59 5.75 6.00 5.72 6.258
P/FCF 55.29 47.22 53.55 44.80 40.54 22.34 16.45 18.05 19.94 26.10 26.91 45.30 -7134.38 -81.49 -38.97 -35.30 -36.09 43.84 49.87 29.61 29.606
P/OCF 18.35 15.44 17.22 14.40 12.67 12.40 12.92 14.17 19.94 26.10 26.91 32.90 77.92 496.09 — — — 23.37 25.95 18.53 18.531
EV/EBITDA 10.27 7.60 7.28 6.92 6.92 7.07 8.29 15.61 17.53 24.58 73.81 12.62 16.27 21.06 14.48 20.01 26.03 21.30 21.20 21.53 21.529
EV/Revenue 1.90 1.41 1.41 1.21 1.10 1.13 1.18 1.31 1.69 2.14 2.30 2.04 2.66 3.59 3.22 3.42 3.77 3.35 3.40 3.51 3.508
EV/EBIT 12.11 8.97 8.52 8.07 8.28 8.60 10.02 26.17 27.30 41.32 -202.53 16.31 21.09 26.33 17.04 24.78 33.05 25.74 26.06 27.16 27.158
EV/FCF 67.01 55.04 62.12 53.95 50.02 28.49 20.59 22.80 23.54 30.25 31.20 44.58 -7045.13 -81.04 -38.74 -35.90 -36.64 42.46 48.36 29.32 29.315
Earnings Yield 5.6% 7.4% 6.9% 7.6% 7.7% 7.6% 7.4% 2.3% 1.3% -0.4% -3.0% -5.6% -3.8% -1.9% -0.4% 2.3% 1.5% 1.8% 1.9% 2.3% 2.26%
FCF Yield 1.8% 2.1% 1.9% 2.2% 2.5% 4.5% 6.1% 5.5% 5.0% 3.8% 3.7% 2.2% -0.0% -1.2% -2.6% -2.8% -2.8% 2.3% 2.0% 3.4% 3.38%
PEG Ratio snapshot only 0.264
Price/Tangible Book snapshot only 7.515
EV/OCF snapshot only 18.349
EV/Gross Profit snapshot only 7.369
Acquirers Multiple snapshot only 17.475
Shareholder Yield snapshot only 0.12%
Graham Number snapshot only $635.93
Leverage & Solvency
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Current Ratio 1.75 1.69 1.69 1.77 1.77 2.13 2.13 2.10 2.10 1.93 1.93 1.28 1.28 1.46 1.46 1.56 1.56 1.65 1.65 1.77 1.772
Quick Ratio 1.21 1.16 1.16 1.23 1.23 1.45 1.45 1.64 1.64 1.48 1.48 0.84 0.84 1.00 1.00 1.01 1.01 1.17 1.17 1.23 1.234
Debt/Equity 0.71 0.45 0.45 0.44 0.44 0.44 0.44 0.49 0.49 0.56 0.56 0.16 0.16 0.21 0.21 0.28 0.28 0.13 0.13 0.06 0.056
Net Debt/Equity 0.54 0.27 0.27 0.28 0.28 0.31 0.31 0.36 0.36 0.41 0.41 -0.06 -0.06 -0.03 -0.03 0.09 0.09 -0.18 -0.18 -0.06 -0.056
Debt/Assets 0.32 0.23 0.23 0.23 0.23 0.24 0.24 0.24 0.24 0.26 0.26 0.09 0.09 0.12 0.12 0.15 0.15 0.06 0.06 0.03 0.030
Debt/EBITDA 2.33 1.79 1.66 1.85 2.06 2.16 2.36 4.37 3.60 4.56 13.73 0.59 0.59 0.80 0.57 1.09 1.28 0.49 0.47 0.21 0.215
Net Debt/EBITDA 1.80 1.08 1.00 1.17 1.31 1.53 1.67 3.25 2.69 3.37 10.15 -0.21 -0.21 -0.12 -0.08 0.33 0.39 -0.69 -0.66 -0.21 -0.214
Interest Coverage 5.41 5.72 6.81 6.17 5.68 5.46 4.55 1.80 2.05 1.54 -0.29 3.15 3.65 4.80 9.16 8.87 6.73 8.50 9.18 10.51 10.509
Equity Multiplier 2.21 1.92 1.92 1.88 1.88 1.88 1.88 2.04 2.04 2.14 2.14 1.83 1.83 1.80 1.80 1.81 1.81 1.98 1.98 1.89 1.894
Cash Ratio snapshot only 0.186
Debt Service Coverage snapshot only 13.256
Cash to Debt snapshot only 1.997
FCF to Debt snapshot only 3.424
Defensive Interval snapshot only 480.1 days
Efficiency & Turnover
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Asset Turnover 0.76 0.74 0.77 0.75 0.74 0.71 0.73 0.69 0.73 0.69 0.64 0.77 0.76 0.74 0.79 0.87 0.88 0.93 0.96 0.94 0.945
Inventory Turnover 1.89 1.81 1.88 1.90 1.85 1.65 1.68 2.15 2.24 1.99 1.94 1.89 1.84 1.59 1.61 1.56 1.84 2.20 2.60 2.65 2.652
Receivables Turnover 4.64 4.32 4.46 4.34 4.25 4.01 4.10 4.03 4.23 4.01 3.71 5.18 5.12 4.31 4.61 5.11 5.12 4.80 4.94 4.09 4.090
Payables Turnover 1.91 1.88 1.95 2.01 1.95 1.88 1.92 2.45 2.55 2.58 2.51 2.04 1.98 2.04 2.07 1.77 2.08 2.54 2.99 2.81 2.815
DSO 79 85 82 84 86 91 89 91 86 91 98 70 71 85 79 71 71 76 74 89 89.3 days
DIO 193 202 195 192 197 222 217 169 163 183 188 193 198 229 226 234 199 166 140 138 137.7 days
DPO 191 194 187 182 187 194 190 149 143 142 145 179 184 179 176 206 175 144 122 130 129.7 days
Cash Conversion Cycle 81 93 90 94 96 119 116 111 106 133 141 84 85 135 129 99 95 98 92 97 97.2 days
Fixed Asset Turnover snapshot only 3.933
Operating Cycle snapshot only 226.9 days
Cash Velocity snapshot only 14.330
Capital Intensity snapshot only 1.172
Growth (YoY)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 8.3% 9.2% 12.1% 13.0% 4.3% 4.4% 3.4% 2.5% 9.8% 6.3% -3.7% 3.1% -2.9% 0.1% 15.5% 2.2% 3.6% 21.8% 17.3% 27.8% 27.76%
Net Income 11.1% 16.3% 6.6% -2.9% -19.1% -20.6% -13.6% -68.4% -69.2% -1.1% -1.8% -6.1% -6.1% -9.0% 75.3% 1.7% 1.6% 2.2% 7.1% 30.1% 30.06%
EPS 11.1% 16.4% 6.5% -3.0% -19.1% -20.6% -13.6% -68.4% -69.2% -1.1% -1.8% -6.1% -6.2% -9.0% 75.3% 1.7% 1.6% 2.2% 7.1% 33.9% 33.93%
FCF -10.9% -34.6% -40.3% -22.2% -18.9% 61.9% 1.6% 1.6% 2.6% 89.2% 23.4% -17.6% -1.0% -1.6% -2.3% -3.1% -281.4% 3.2% 2.0% 2.6% 2.60%
EBITDA 22.9% 20.3% 25.2% 8.5% -10.1% -10.0% -23.6% -50.8% -33.5% -42.2% -79.0% 99.3% 64.4% 95.9% 7.2% 8.1% -8.2% 12.4% -15.6% 21.7% 21.68%
Op. Income 20.7% 23.7% 30.5% 22.4% 7.3% -1.5% -7.7% 14.6% 29.3% 39.5% 13.7% -10.0% -17.0% -12.7% 28.9% 12.0% -14.0% -19.2% -50.6% -17.1% -17.12%
OCF Growth snapshot only 9.00%
Asset Growth snapshot only 24.04%
Equity Growth snapshot only 18.79%
Debt Growth snapshot only -76.00%
Shares Change snapshot only -2.89%
Dividend Growth snapshot only -31.44%
Growth (CAGR)
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue 3Y 9.2% 8.6% 8.4% 7.6% 6.4% 6.2% 6.4% 5.8% 7.4% 6.6% 3.7% 6.1% 3.6% 3.6% 4.8% 2.6% 3.4% 9.0% 9.3% 10.4% 10.41%
Revenue 5Y 8.0% 7.6% 6.4% 6.3% 4.9% 5.3% 6.5% 6.8% 8.3% 7.3% 4.9% 5.7% 5.1% 5.0% 6.0% 4.5% 4.5% 8.1% 8.6% 9.3% 9.30%
EPS 3Y 13.4% 5.1% 3.6% 0.6% 0.7% 7.8% 5.8% -27.4% -34.9% — — — — — — 2.6% -3.1% 6.7% 6.5% 66.1% 66.08%
EPS 5Y 7.0% 6.9% -0.4% 0.5% -4.2% -3.8% 6.5% -18.0% -18.4% — — — — — — 5.5% -3.9% 2.3% 2.1% 7.0% 7.01%
Net Income 3Y 13.4% 5.1% 3.6% 0.6% 0.7% 7.8% 5.7% -27.4% -34.8% — — — — — — 3.6% -3.1% 6.7% 6.5% 66.1% 66.09%
Net Income 5Y 7.0% 6.9% -0.4% 0.6% -4.2% -3.8% 6.5% -18.0% -18.3% — — — — — — 6.2% -3.9% 2.3% 2.2% 7.0% 7.02%
EBITDA 3Y 18.6% 17.9% 17.7% 12.3% 8.4% 7.7% 3.8% -13.1% -9.7% -14.4% -41.4% 2.1% -0.5% 0.7% 9.8% 2.0% 0.2% 8.4% 13.5% 37.9% 37.89%
EBITDA 5Y 10.4% 10.2% 6.4% 6.2% 1.5% 2.8% 7.2% -6.3% -0.1% -3.1% -23.5% 6.8% 6.8% 7.2% 14.1% 7.1% 2.1% 6.6% 7.0% 7.0% 6.97%
Gross Profit 3Y 8.9% 8.2% 7.7% 6.8% 5.7% 6.0% 6.2% 2.7% 4.4% 3.3% -1.0% 6.0% 4.2% 5.1% 7.4% 4.2% 1.5% 5.3% 1.7% 3.1% 3.14%
Gross Profit 5Y 6.3% 5.5% 3.8% 3.8% 2.5% 3.4% 5.5% 4.4% 6.3% 5.1% 1.8% 5.7% 5.2% 5.7% 7.3% 5.2% 3.2% 5.9% 4.0% 2.8% 2.81%
Op. Income 3Y 18.4% 17.0% 15.5% 20.4% 17.2% 14.5% 13.6% 15.8% 18.7% 19.3% 11.1% 8.1% 4.8% 6.2% 10.6% 4.9% -2.6% -0.6% -10.2% -5.8% -5.82%
Op. Income 5Y 21.9% 22.0% 17.2% 19.2% 6.9% 1.5% -0.1% 13.0% 18.2% 17.1% 10.1% 12.5% 11.6% 12.8% 16.5% 9.4% 3.6% 3.7% -2.7% 3.2% 3.22%
FCF 3Y -8.7% -20.7% -16.6% -7.3% 7.1% 77.7% 58.8% 38.1% 37.3% 26.1% 24.7% 19.0% — — — — — 37.0% 16.8% 41.2% 41.16%
FCF 5Y — — — — — — 54.4% 23.0% 17.2% 8.9% 13.5% 11.5% — — — — — 22.2% 20.1% 41.9% 41.86%
OCF 3Y -11.0% -17.6% -18.2% -16.8% -15.4% -12.8% -11.8% -12.2% -11.5% -12.8% -13.8% -8.0% -23.4% -53.1% — — — 38.9% 34.0% 52.3% 52.25%
OCF 5Y 21.1% 21.7% 15.1% 11.3% 8.0% 6.0% 0.4% -4.4% -7.4% -10.9% -10.6% -11.2% -20.6% -41.0% — — — 11.1% 9.7% 25.3% 25.27%
Assets 3Y 6.2% 5.8% 5.8% 8.7% 8.7% 9.2% 9.2% 9.7% 9.7% 9.9% 9.9% -2.7% -2.7% -2.8% -2.8% -2.1% -2.1% 1.8% 1.8% 0.9% 0.91%
Assets 5Y 7.6% 4.7% 4.7% 6.9% 6.9% 6.7% 6.7% 8.3% 8.3% 7.3% 7.3% 1.6% 1.6% 1.9% 1.9% 1.8% 1.8% 4.7% 4.7% 5.0% 4.99%
Equity 3Y 8.1% 13.6% 13.6% 17.5% 17.5% 17.5% 17.5% 16.0% 16.0% 12.8% 12.8% 3.6% 3.6% -0.8% -0.8% -0.9% -0.9% 0.0% 0.0% 3.5% 3.53%
Book Value 3Y 8.1% 13.6% 13.6% 17.4% 17.5% 17.5% 17.6% 16.0% 16.0% 12.8% 12.8% 3.6% 3.6% -0.8% -0.8% -1.8% -0.9% 0.0% 0.0% 3.5% 3.52%
Dividend 3Y 26.9% — 45.5% 45.5% 18.9% -8.0% -24.0% -24.0% — — — 8.3% — — — 51.8% 16.9% -9.9% -23.4% -12.7% -12.69%
Growth Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Revenue Stability 0.98 0.98 0.93 0.93 0.95 0.96 0.97 0.97 0.99 0.99 0.84 0.95 0.91 0.96 0.83 0.94 0.86 0.86 0.83 0.80 0.798
Earnings Stability 0.23 0.11 0.05 0.10 0.00 0.01 0.43 0.24 0.17 0.31 0.38 0.57 0.59 0.61 0.52 0.13 0.26 0.18 0.11 0.00 0.001
Margin Stability 0.97 0.96 0.95 0.95 0.95 0.96 0.98 0.96 0.96 0.96 0.94 0.96 0.96 0.95 0.93 0.95 0.96 0.94 0.89 0.87 0.873
Rev. Growth Consistency 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 0.00 1.00 0.00 1.00 0.50 1.00 0.50 1.00 1.00 1.00 1.000
Earn. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.96 0.93 0.97 0.99 0.92 0.92 0.95 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.50 0.20 0.20 0.20 0.20 0.50 0.500
Earnings Smoothness 0.90 0.85 0.94 0.97 0.79 0.77 0.85 0.00 0.00 — — — — — — — — — — 0.74 0.739
ROE Trend -0.00 -0.00 -0.02 -0.03 -0.06 -0.04 -0.04 -0.09 -0.09 -0.11 -0.18 -0.26 -0.23 -0.14 -0.03 0.20 0.16 0.16 0.16 0.17 0.166
Gross Margin Trend -0.00 -0.00 -0.01 -0.01 -0.01 0.00 0.00 -0.05 -0.05 -0.06 -0.08 0.04 0.04 0.06 0.09 0.05 -0.02 -0.05 -0.11 -0.18 -0.176
FCF Margin Trend 0.00 -0.00 -0.01 -0.01 -0.01 0.01 0.02 0.03 0.05 0.04 0.03 0.01 -0.05 -0.10 -0.15 -0.15 -0.14 0.07 0.07 0.14 0.144
Sustainable Growth Rate 15.0% 13.1% 12.8% 11.0% 9.5% 8.7% 9.4% 3.0% 2.7% — — — — — — 11.3% 7.9% 10.5% 11.2% 13.3% 13.34%
Internal Growth Rate 7.0% 6.7% 6.5% 5.8% 4.9% 4.8% 5.2% 1.5% 1.4% — — — — — — 6.6% 4.5% 5.8% 6.3% 7.7% 7.74%
Cash Flow Quality
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
OCF/Net Income 0.97 0.88 0.84 0.91 1.03 1.06 1.05 3.09 3.74 -10.53 -1.25 -0.55 -0.34 -0.11 1.51 -0.39 -0.73 2.33 2.08 2.38 2.384
FCF/OCF 0.33 0.33 0.32 0.32 0.31 0.56 0.79 0.79 1.00 1.00 1.00 0.73 -0.01 -6.09 4.38 3.12 2.51 0.53 0.52 0.63 0.626
FCF/Net Income snapshot only 1.492
OCF/EBITDA snapshot only 1.173
CapEx/Revenue 5.7% 5.3% 4.8% 4.7% 4.9% 3.2% 1.6% 1.6% 0.0% 0.0% 0.0% 1.7% 3.5% 5.2% 6.4% 6.5% 6.2% 6.9% 6.5% 7.2% 7.15%
CapEx/Depreciation snapshot only 2.118
Accruals Ratio 0.00 0.01 0.01 0.01 -0.00 -0.00 -0.00 -0.03 -0.04 -0.05 -0.08 -0.14 -0.10 -0.06 0.01 0.10 0.09 -0.08 -0.07 -0.10 -0.105
Sloan Accruals snapshot only 0.057
Cash Flow Adequacy snapshot only 2.526
Earnings Quality Score snapshot only 0.750
Dividends & Buybacks
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Dividend Yield 0.2% 0.4% 0.4% 0.4% 0.5% 0.4% 0.2% 0.2% 0.0% 0.0% 0.0% 0.1% 0.2% 0.2% 0.3% 0.2% 0.2% 0.1% 0.1% 0.1% 0.21%
Dividend/Share $1.23 $1.86 $1.87 $1.87 $2.07 $1.45 $0.82 $0.82 $0.00 $0.00 $0.00 $1.04 $2.09 $3.13 $4.17 $3.64 $3.33 $2.29 $1.87 $2.50 $5.00
Payout Ratio 3.4% 5.0% 5.2% 5.6% 7.1% 4.9% 2.6% 7.8% 0.0% — — — — — — 10.1% 12.5% 6.4% 5.0% 5.2% 5.18%
FCF Payout Ratio 10.6% 17.4% 19.2% 19.2% 22.0% 8.4% 3.2% 3.2% 0.0% 0.0% 0.0% 4.9% — — — — — 5.2% 4.6% 3.5% 3.47%
Total Payout Ratio 3.4% 5.0% 5.2% 5.6% 7.1% 4.9% 2.6% 7.8% 0.0% — — — — — — 10.1% 12.5% 6.4% 5.0% 5.2% 5.18%
Div. Increase Streak 0 0 1 1 1 0 0 0 — — — 0 0 0 0 1 1 0 0 0 0
Chowder Number 1.05 — 2.09 2.09 0.69 -0.22 -0.56 -0.56 — — — 0.27 — — — 2.60 0.60 -0.27 -0.55 -0.33 -0.333
Buyback Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield 0.0% 0.0% 0.0% 0.0% -2.3% -2.3% -2.1% -1.9% 0.0% 0.0% 0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.0% -0.02%
Total Shareholder Return 0.2% 0.4% 0.4% 0.4% -1.8% -1.9% -1.9% -1.8% 0.0% 0.0% 0.0% 0.1% 0.2% 0.2% 0.3% 0.2% 0.2% 0.1% 0.1% 0.1% 0.09%
DuPont Factors
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Tax Burden (NI/EBT) 0.70 0.69 0.68 0.65 0.59 0.55 0.54 0.44 0.43 10.51 0.71 -6.87 -3.77 -0.93 -0.09 0.75 0.73 0.66 0.66 0.69 0.686
Interest Burden (EBT/EBIT) 0.81 0.82 0.75 0.78 0.88 0.93 1.10 1.07 0.73 -0.01 7.27 0.13 0.21 0.53 0.73 0.76 0.68 0.74 0.75 0.90 0.905
EBIT Margin 0.16 0.16 0.17 0.15 0.13 0.13 0.12 0.05 0.06 0.05 -0.01 0.13 0.13 0.14 0.19 0.14 0.11 0.13 0.13 0.13 0.129
Asset Turnover 0.76 0.74 0.77 0.75 0.74 0.71 0.73 0.69 0.73 0.69 0.64 0.77 0.76 0.74 0.79 0.87 0.88 0.93 0.96 0.94 0.945
Equity Multiplier 2.31 2.09 2.09 2.02 2.02 1.90 1.90 1.96 1.96 2.01 2.01 1.95 1.95 1.98 1.98 1.82 1.82 1.90 1.90 1.86 1.857
Per Share
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
EPS (Diluted TTM) $36.23 $37.07 $36.13 $33.35 $29.32 $29.43 $31.23 $10.53 $9.02 $-3.10 $-25.22 $-53.21 $-46.48 $-31.02 $-6.23 $36.03 $26.69 $35.77 $37.72 $48.25 $48.25
Book Value/Share $250.29 $306.91 $306.79 $321.80 $321.88 $339.27 $339.26 $335.75 $335.52 $330.08 $330.48 $278.09 $278.15 $299.30 $299.27 $304.50 $313.41 $339.41 $339.35 $372.48 $372.49
Tangible Book/Share $167.57 $221.93 $221.84 $240.86 $240.92 $253.56 $253.55 $250.12 $249.95 $244.21 $244.50 $230.80 $230.85 $251.40 $251.37 $254.25 $261.70 $275.25 $275.20 $283.67 $283.67
Revenue/Share $409.71 $417.34 $430.84 $435.77 $427.15 $435.90 $445.69 $447.14 $468.94 $462.66 $429.31 $461.04 $455.56 $463.54 $495.80 $457.37 $471.49 $564.12 $581.09 $601.74 $628.51
FCF/Share $11.61 $10.68 $9.75 $9.75 $9.41 $17.30 $25.64 $25.60 $33.72 $32.68 $31.65 $21.10 $-0.17 $-20.51 $-41.24 $-43.60 $-48.54 $44.48 $40.81 $72.00 $82.75
OCF/Share $34.97 $32.66 $30.33 $30.33 $30.13 $31.16 $32.64 $32.60 $33.72 $32.68 $31.65 $29.06 $15.75 $3.37 $-9.41 $-13.97 $-19.36 $83.43 $78.44 $115.04 $100.48
Cash/Share $40.65 $54.53 $54.51 $51.12 $51.13 $43.95 $43.95 $41.58 $41.55 $47.78 $47.83 $58.97 $58.98 $72.32 $72.31 $58.89 $60.62 $104.79 $104.77 $41.99 $41.68
EBITDA/Share $75.70 $77.36 $83.25 $75.94 $68.04 $69.67 $63.67 $37.40 $45.27 $40.23 $13.38 $74.52 $74.49 $78.92 $110.37 $78.24 $68.34 $88.69 $93.11 $98.04 $98.04
Debt/Share $176.64 $138.08 $138.03 $140.31 $140.35 $150.25 $150.25 $163.30 $163.19 $183.38 $183.60 $43.62 $43.63 $63.11 $63.10 $85.08 $87.57 $43.36 $43.35 $21.03 $21.03
Net Debt/Share $135.99 $83.56 $83.52 $89.20 $89.22 $106.30 $106.30 $121.72 $121.64 $135.60 $135.77 $-15.35 $-15.35 $-9.21 $-9.21 $26.19 $26.96 $-61.43 $-61.42 $-20.96 $-20.96
Academic Models
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 6.050
Altman Z-Prime snapshot only 10.704
Piotroski F-Score 7 6 5 5 6 7 5 5 6 3 2 5 6 6 5 3 3 7 7 8 8
Beneish M-Score -2.31 -2.36 -2.33 -2.26 -2.31 -2.35 -2.37 -2.20 -2.56 -2.72 -2.78 -3.87 -3.58 -3.10 -2.67 -0.65 -0.76 -2.02 -2.07 -2.30 -2.298
Ohlson O-Score snapshot only -10.236
ROIC (Greenblatt) snapshot only 23.74%
Net-Net WC snapshot only $67.45
EVA snapshot only $13471269023.57
Credit
Metric Trend Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Q2'26 Q3'26 Q4'26 Current
Credit Rating snapshot only AA+
Credit Score 67.76 60.81 67.29 72.04 66.73 64.93 60.96 55.87 66.35 48.52 37.65 80.65 73.21 71.06 76.96 76.59 73.67 88.70 89.03 92.02 92.023
Credit Grade snapshot only 2
Credit Trend snapshot only 15.434
Implied Spread (bps) snapshot only 65.000
Industry Credit Rank snapshot only 82
Sector Credit Rank snapshot only 88

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms